Topiramate in pregnancy - Preliminary experience from the UK epilepsy and pregnancy register


Autoria(s): Hunt, S.; Russell, A.; Smithson, W.H.; Parsons, L.; Robertson, I.; Waddell, R.; Irwin, B.; Morrison, Patrick; Morrow, J.; Craig, J.
Data(s)

22/07/2008

Resumo

Objectives: Topiramate (Topamax (R)) is licensed to be used, either in monotherapy or as adjunctive treatment, for generalized tonic clonic seizures or partial seizures with or without secondary generalization and for prevention of migraine. The safety of topiramate in human pregnancy is largely unknown. Here we report on our experience of pregnancies exposed to topiramate.

Identificador

http://pure.qub.ac.uk/portal/en/publications/topiramate-in-pregnancy--preliminary-experience-from-the-uk-epilepsy-and-pregnancy-register(3c7d7aae-3d1b-4c4e-b5d5-7b4bf71bcea4).html

Idioma(s)

eng

Direitos

info:eu-repo/semantics/restrictedAccess

Fonte

Hunt , S , Russell , A , Smithson , W H , Parsons , L , Robertson , I , Waddell , R , Irwin , B , Morrison , P , Morrow , J & Craig , J 2008 , ' Topiramate in pregnancy - Preliminary experience from the UK epilepsy and pregnancy register ' Neurology , vol 71 , no. 4 , pp. 272-276 .

Palavras-Chave #/dk/atira/pure/subjectarea/asjc/2700/2728 #Clinical Neurology #/dk/atira/pure/subjectarea/asjc/2800 #Neuroscience(all)
Tipo

article